Nicole Nahmod, PA
Surgical · Charlottesville, VANPI 1548839467
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $517 and has fallen 65.1% since, to $181 in 2024.
Across 60 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$259
- AbbVie$166
- Biohaven Pharmaceutical Holding Company Ltd.$153
- Amgen$95
- GRT US Holding, Inc.$73
- Lilly USA, LLC$67
- plus $331 from 10 others
What the payments were for
- Food & beverage$1,143100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 16 | $259 |
| AbbVie | 7 | $166 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $153 |
| Amgen | 3 | $95 |
| GRT US Holding, Inc. | 4 | $73 |
| Lilly USA, LLC | 5 | $67 |
| Medtronic | 3 | $53 |
| Vertos Medical, Inc. | 4 | $53 |
| Pfizer | 3 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Nevro Corp. | 1 | $34 |
| Averitas Pharma Inc. | 2 | $29 |
| Abbott | 2 | $28 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| Bioventus LLC | 1 | $13 |
How this compares
$1,143 in reported general payments places this provider in the 75th percentile of 201 surgical providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 125 | $31,850 |
| Xtampza ErOxycodone Myristate | 57 | $31,401 |
| BelbucaBuprenorphine Hcl | 27 | $19,423 |
| OxycontinOxycodone Hcl | 32 | $14,059 |
| Pregabalin | 330 | $8,837 |
| NucyntaTapentadol Hcl | 11 | $8,605 |
| Morphine Sulfate ErMorphine Sulfate | 324 | $8,237 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 346 | $6,572 |
| Fentanyl | 56 | $6,059 |
| SavellaMilnacipran Hcl | 12 | $5,752 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 268 | $5,214 |
| Diclofenac Sodium | 80 | $3,565 |
| Gabapentin | 284 | $3,528 |
| Tramadol Hcl | 349 | $3,159 |
| Oxycodone Hcl | 219 | $3,002 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta | $259 | $59,42895 claims |
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone, Morphine Sulfate | $21 | $35,550271 claims |
| AbbVieSavella | $166 | $5,75212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 201 surgical providers in Virginia.
Other surgical in Charlottesville
- Rebecca LehmanCharlottesville$11K
- Kathryn RobertsonCharlottesville$8K
- Taylor FrickeCharlottesville$6K
- Evan TurnbullCharlottesville$4K
- Kelli HughesCharlottesville$3K
- Michelle PostCharlottesville$1K
- Rosemarie TygerCharlottesville$1K
- Jeanine GargiuloAlexandria$298K
- Kelly LohmannWoodbridge$88K
- Alan FitchRichmond$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.